Cerecor Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CERC research report →
Companywww.cerecor.com
Cerecor Inc. , a biopharmaceutical company, focuses on development and commercialization of treatments for rare pediatric and orphan diseases. It develop therapies for the treatment of inherited metabolic disorders, such as CERC-801 and CERC-802, which completed the phase I clinical trial; and CERC-803.
- CEO
- Michael Cola
- IPO
- 2015
- Employees
- 30
- HQ
- Rockville, MD, US
Price Chart
Valuation
- Market Cap
- $38.63M
- P/E
- -0.60
- P/S
- -184.83
- P/B
- 0.86
- EV/EBITDA
- -0.17
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 64.11%
- Op Margin
- 37874.64%
- Net Margin
- 46836.84%
- ROE
- -112.68%
- ROIC
- -89.66%
Growth & Income
- Revenue
- $59.00K · -86.62%
- Net Income
- $-78,259,000 · -122.78%
- EPS
- $-5.84 · -74.80%
- Op Income
- $-72,925,000
- FCF YoY
- -4.90%
Performance & Tape
- 52W High
- $4.50
- 52W Low
- $1.98
- 50D MA
- $2.87
- 200D MA
- $3.04
- Beta
- 1.44
- Avg Volume
- 639.17K
Get TickerSpark's AI analysis on CERC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 18, 21 | ARMISTICE CAPITAL, LLC | buy | 20,000 |
| Aug 16, 21 | ARMISTICE CAPITAL, LLC | buy | 30,000 |
| Jul 1, 21 | COLA MICHAEL F | other | 51,740 |
| Jun 30, 21 | Bruhn Suzanne Louise | other | 3,465 |
| Jun 30, 21 | KAPLAN GILLA | other | 6,353 |
| Jun 30, 21 | Miller Joseph M | other | 4,620 |
| Jun 30, 21 | Persson Magnus | other | 3,985 |
| Jun 15, 21 | Persson Magnus | other | 40,000 |
| Jun 15, 21 | Miller Joseph M | other | 40,000 |
| Jun 15, 21 | Bruhn Suzanne Louise | other | 40,000 |
Our CERC Coverage
We haven't published any research on CERC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate CERC Report →